Effect of different adjuvants in equines for the production of equine rabies immunoglobulin

National Medical Journal of India

Volumn 18, Issue 6, 2005, Pages 289-292

  Arora, Shivali ^a   Sharma, Sourabh ^a   Goel, Sunil K ^a   Singh, Usha Soren ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BENTONITE; FREUND ADJUVANT; IMMUNOLOGICAL ADJUVANT; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HORSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; INJECTION SITE ABSCESS; MALE; MYCOBACTERIUM BUTYRICUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RABIES; VACCINE PRODUCTION; VIRUS IMMUNITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHICK EMBRYO; FREUND'S ADJUVANT; HORSES; IMMUNOGLOBULINS; RABIES; RABIES VACCINES;

EID: 32544445853     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. World Health Organization. Recommendation on rabies post-exposure treatment in emerging and other communicable diseases surveillance and control. Geneva:WHO; 1996:3.
2. Goel SK, Sharma S, Singh US. Antibody response to purified chick embryo cell vaccine in equines for production of equine rabies immunoglobulin. Biologicals 2003;31:233-6.
3. Ramon G. Sur I augmentation anormale de I'antitoxine chezles Chavaux produeteurs de Serum antidiptherique. Bull Soc Centre Med Vet 1925;101:201-34.
4. Christensen PA. The production of anti-snakebite serum. In: Agerholm P (ed). South African snake venoms and antivenins. Johannesburg: The South African Institute for Medical Research; 1955:52-7.
5. Elgert KD. Immunomodulations. In: Elgert KD (ed). Immunology. Understanding the immune system. New York: John Wiley; 1986:371.
6. Care and management of equines used in the production of biologicals. CPCSEA Protocol II. Chennai:CPCSEA; 2001:1-40
7. Fitzgerald EA. Potency test for ARS and immunoglobulin. In: Meslin FX (ed). Laboratory techniques in rabies. 4th ed. Geneva: WHO; 1996:417-22.
8. Reed T, Muench H. A simple method for estimating 50% end point. Am J Hyg 1938;27:493-7.
9. Luekrajang T, Wangsai J, Phanupak LP. Production of antirabies serum of equine origin. In: Meslin FX, Kaplan MM, Koprowski H (ed). Laboratory techniques in rabies. 4th ed. Geneva: WHO; 1996:401-4.
10. Freund J, Lipton MM, Pisani TM. Immune response to rabies: Vaccine in water-in-oil emulsion. Proc Soc Exp Biol 1948;68:609-10.
11. White RGM. Factors affecting the antibody response. Br Med Bull 1963;1:207-13.
12. Abramoff P, Lavia MF. Immunoenhancement. In: Young JR, Mobley S (eds). Biology of the immune response. New York:McGraw-Hill; 1970:260-9.
13. Chowdhuri AN, Thomas AK. Rabies: General considerations and laboratory procedures. New Delhi:ICMR/SRS; 1967;110-12.
14. Lodmell DL, Ewalt LC. Rabies vaccination: Comparison of neutralizing antibody responses after priming and boosting with different combinations of DNA, inactivated virus, or recombinant vaccinia virus vaccines. Vaccine 2000;18:2394-8.